1470 nm双波长激光和等离子治疗良性前列腺增生的临床分析（附364例报告）

Clinical analysis of 364 cases of benign prostatic hyperplasia treated with 1470 nm dual wavelength laser and plasma

摘要:

摘要：目的??比较1470 nm双波长激光和等离子治疗良性前列腺增生（BPH）的临床疗效和安全性。方法?分析2015年2月－2018年3月于该院住院治疗的364例BPH患者的临床病例资料，其中采用1470 nm双波长激光治疗BPH患者176例；采用等离子治疗的患者188例。比较两种治疗方式的手术时间、术中出血量、平均住院日、术后泌尿系感染、术后尿道狭窄和术后尿失禁等的差异。结果?对于较小体积前列腺患者（< 50 g），两组手术时间差异无统计学意义，对于较大体积前列腺患者（≥50 g），激光组平均手术时间明显少于等离子组，差异有统计学意义（P <0.05）；激光组术中出血量和平均住院日明显少于等离子组，差异有统计学意义（P <0.05）；术后泌尿系感染、尿道狭窄和真性尿失禁等差异无统计学意义。结论?对于小体积前列腺可以考虑1470 nm双波长激光和等离子治疗，对于较大体积的前列腺，1470 nm双波长激光组有较大的优势。

Abstract:

Abstract: Objective?To compare the clinical efficacy and safety of 1470 nm dual wavelength laser and plasma in treatment of benign prostatic hyperplasia.?Methods?Clinical data of 364 patients with prostatic hyperplasia hospitalized from February 2015 to March 2018. 176 cases of benign prostatic hyperplasia were treated with 1470 nm dual wavelength laser and 188 patients were treated by plasma. The operative time, intraoperative bleeding, average time of hospital stay, postoperative urinary tract infection, postoperative urethral stricture and postoperative urinary incontinence were compared between the two groups.?Results?For the patients with smaller prostate volume (﹤ 50 g), there was no statistical difference between the two groups. For the larger prostate volume (≥ 50 g), the mean operation time of the laser group was significantly less than the average operation time of the plasma group. The difference was statistically significant, and the intraoperative bleeding and the average hospitalization days were significantly less than that of the plasma group. In the plasma group, there was no significant difference in postoperative urinary tract infection, urethral stricture and genuine urinary incontinence.?Conclusion?For small volume prostate can be considered 1470 nm dual wavelength laser and plasma treatment for large volume prostate, 1470 nm dual wavelength laser group has a great advantage.